Oxidative stress events and neuronal dysfunction in alzheimer’s disease: Focus on APE1/ref-1-mediated survival strategies

Navrattan Kaur, Bibekananda Sarkar, Sunil Mittal, Monisha Dhiman, Giulio Taglialatela, Regino J. Perez-Polo, Anil K. Mantha

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is an important public health problem which affects millions of people worldwide. The major pathological hallmarks associated with AD are the accumulation of amyloid beta (Aβ) in senile plaques and neurofibrillary tangles (NFT) made up of hyperphosphorylated tau proteins. New findings suggest that oligomeric Aβ is a more toxic species than fibrillar Aβ relevant to AD pathology. Although the molecular mechanism(s) underlying the disease is not identified completely, various factors have been implicated in the development of AD. Accumulating evidences point towards the role of oxidative stress and mitochondrial dysfunction in the pathogenesis of AD and recognise them as an early event in AD development. Ageing is considered the greatest risk factor for AD and is linked to oxidative stress which causes accumulation of somatic mutations in mitochondrial DNA (mtDNA) over time and leads to genome instability and mitochondrial dysfunction. Recent studies on AD patients and transgenic mouse models suggest that amyloid precursor protein (APP) and Aβ localise to mitochondria, interact with mitochondrial proteins, disrupt electron transport chain (ETC), increases reactive oxygen species (ROS) level, impair axonal mitochondrial trafficking, thus leading to synaptic damage and cognitive decline associated with AD. It is not known whether accumulation of Aβ is the cause or outcome of declining mitochondrial function in AD. In order to counteract oxidative stress and maintain genome integrity, various DNA repair pathways exist, base excision repair (BER) pathway being the predominant pathway for repairing oxidised base lesions in neuronal cells. APE1 is the central enzyme of the BER pathway, having both repair and redox activities and shown to enhance neuronal survival after oxidative stress. Newer studies are revealing the role of APE1 in maintenance of mitochondrial genome repair and function. In this scenario, antioxidant-based therapy, which could reduce oxidative stress and modulate the activities of APE1, can serve as effective treatment providing neuroprotection in AD. This book chapter summarises some recent developments in understanding the pathogenesis of AD linking Aβ-induced oxidative stress, mitochondrial dysfunction, role of APE1 and phytochemicals toward AD therapeutics.

Original languageEnglish (US)
Title of host publicationFree Radicals in Human Health and Disease
PublisherSpringer India
Pages175-207
Number of pages33
ISBN (Print)9788132220350, 9788132220343
DOIs
StatePublished - Jan 1 2015

Fingerprint

Oxidative stress
Alzheimer Disease
Oxidative Stress
Survival
Repair
DNA Repair
Serum Amyloid A Protein
Genes
tau Proteins
Neurofibrillary Tangles
Mitochondrial Genome
Amyloid beta-Protein Precursor
Genomic Instability
Poisons
Mitochondrial Proteins
Mitochondria
Amyloid Plaques
Phytochemicals
Electron Transport
Staphylococcal Protein A

Keywords

  • Alzheimer’s disease
  • Amyloid beta
  • APE1/Ref-1
  • Mitochondria
  • Oxidative stress
  • Phytochemicals

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kaur, N., Sarkar, B., Mittal, S., Dhiman, M., Taglialatela, G., Perez-Polo, R. J., & Mantha, A. K. (2015). Oxidative stress events and neuronal dysfunction in alzheimer’s disease: Focus on APE1/ref-1-mediated survival strategies. In Free Radicals in Human Health and Disease (pp. 175-207). Springer India. https://doi.org/10.1007/978-81-322-2035-0_13

Oxidative stress events and neuronal dysfunction in alzheimer’s disease : Focus on APE1/ref-1-mediated survival strategies. / Kaur, Navrattan; Sarkar, Bibekananda; Mittal, Sunil; Dhiman, Monisha; Taglialatela, Giulio; Perez-Polo, Regino J.; Mantha, Anil K.

Free Radicals in Human Health and Disease. Springer India, 2015. p. 175-207.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kaur, N, Sarkar, B, Mittal, S, Dhiman, M, Taglialatela, G, Perez-Polo, RJ & Mantha, AK 2015, Oxidative stress events and neuronal dysfunction in alzheimer’s disease: Focus on APE1/ref-1-mediated survival strategies. in Free Radicals in Human Health and Disease. Springer India, pp. 175-207. https://doi.org/10.1007/978-81-322-2035-0_13
Kaur N, Sarkar B, Mittal S, Dhiman M, Taglialatela G, Perez-Polo RJ et al. Oxidative stress events and neuronal dysfunction in alzheimer’s disease: Focus on APE1/ref-1-mediated survival strategies. In Free Radicals in Human Health and Disease. Springer India. 2015. p. 175-207 https://doi.org/10.1007/978-81-322-2035-0_13
Kaur, Navrattan ; Sarkar, Bibekananda ; Mittal, Sunil ; Dhiman, Monisha ; Taglialatela, Giulio ; Perez-Polo, Regino J. ; Mantha, Anil K. / Oxidative stress events and neuronal dysfunction in alzheimer’s disease : Focus on APE1/ref-1-mediated survival strategies. Free Radicals in Human Health and Disease. Springer India, 2015. pp. 175-207
@inbook{cb53dcdab4c44d32a384812de632bfee,
title = "Oxidative stress events and neuronal dysfunction in alzheimer’s disease: Focus on APE1/ref-1-mediated survival strategies",
abstract = "Alzheimer’s disease (AD) is an important public health problem which affects millions of people worldwide. The major pathological hallmarks associated with AD are the accumulation of amyloid beta (Aβ) in senile plaques and neurofibrillary tangles (NFT) made up of hyperphosphorylated tau proteins. New findings suggest that oligomeric Aβ is a more toxic species than fibrillar Aβ relevant to AD pathology. Although the molecular mechanism(s) underlying the disease is not identified completely, various factors have been implicated in the development of AD. Accumulating evidences point towards the role of oxidative stress and mitochondrial dysfunction in the pathogenesis of AD and recognise them as an early event in AD development. Ageing is considered the greatest risk factor for AD and is linked to oxidative stress which causes accumulation of somatic mutations in mitochondrial DNA (mtDNA) over time and leads to genome instability and mitochondrial dysfunction. Recent studies on AD patients and transgenic mouse models suggest that amyloid precursor protein (APP) and Aβ localise to mitochondria, interact with mitochondrial proteins, disrupt electron transport chain (ETC), increases reactive oxygen species (ROS) level, impair axonal mitochondrial trafficking, thus leading to synaptic damage and cognitive decline associated with AD. It is not known whether accumulation of Aβ is the cause or outcome of declining mitochondrial function in AD. In order to counteract oxidative stress and maintain genome integrity, various DNA repair pathways exist, base excision repair (BER) pathway being the predominant pathway for repairing oxidised base lesions in neuronal cells. APE1 is the central enzyme of the BER pathway, having both repair and redox activities and shown to enhance neuronal survival after oxidative stress. Newer studies are revealing the role of APE1 in maintenance of mitochondrial genome repair and function. In this scenario, antioxidant-based therapy, which could reduce oxidative stress and modulate the activities of APE1, can serve as effective treatment providing neuroprotection in AD. This book chapter summarises some recent developments in understanding the pathogenesis of AD linking Aβ-induced oxidative stress, mitochondrial dysfunction, role of APE1 and phytochemicals toward AD therapeutics.",
keywords = "Alzheimer’s disease, Amyloid beta, APE1/Ref-1, Mitochondria, Oxidative stress, Phytochemicals",
author = "Navrattan Kaur and Bibekananda Sarkar and Sunil Mittal and Monisha Dhiman and Giulio Taglialatela and Perez-Polo, {Regino J.} and Mantha, {Anil K.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-81-322-2035-0_13",
language = "English (US)",
isbn = "9788132220350",
pages = "175--207",
booktitle = "Free Radicals in Human Health and Disease",
publisher = "Springer India",

}

TY - CHAP

T1 - Oxidative stress events and neuronal dysfunction in alzheimer’s disease

T2 - Focus on APE1/ref-1-mediated survival strategies

AU - Kaur, Navrattan

AU - Sarkar, Bibekananda

AU - Mittal, Sunil

AU - Dhiman, Monisha

AU - Taglialatela, Giulio

AU - Perez-Polo, Regino J.

AU - Mantha, Anil K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Alzheimer’s disease (AD) is an important public health problem which affects millions of people worldwide. The major pathological hallmarks associated with AD are the accumulation of amyloid beta (Aβ) in senile plaques and neurofibrillary tangles (NFT) made up of hyperphosphorylated tau proteins. New findings suggest that oligomeric Aβ is a more toxic species than fibrillar Aβ relevant to AD pathology. Although the molecular mechanism(s) underlying the disease is not identified completely, various factors have been implicated in the development of AD. Accumulating evidences point towards the role of oxidative stress and mitochondrial dysfunction in the pathogenesis of AD and recognise them as an early event in AD development. Ageing is considered the greatest risk factor for AD and is linked to oxidative stress which causes accumulation of somatic mutations in mitochondrial DNA (mtDNA) over time and leads to genome instability and mitochondrial dysfunction. Recent studies on AD patients and transgenic mouse models suggest that amyloid precursor protein (APP) and Aβ localise to mitochondria, interact with mitochondrial proteins, disrupt electron transport chain (ETC), increases reactive oxygen species (ROS) level, impair axonal mitochondrial trafficking, thus leading to synaptic damage and cognitive decline associated with AD. It is not known whether accumulation of Aβ is the cause or outcome of declining mitochondrial function in AD. In order to counteract oxidative stress and maintain genome integrity, various DNA repair pathways exist, base excision repair (BER) pathway being the predominant pathway for repairing oxidised base lesions in neuronal cells. APE1 is the central enzyme of the BER pathway, having both repair and redox activities and shown to enhance neuronal survival after oxidative stress. Newer studies are revealing the role of APE1 in maintenance of mitochondrial genome repair and function. In this scenario, antioxidant-based therapy, which could reduce oxidative stress and modulate the activities of APE1, can serve as effective treatment providing neuroprotection in AD. This book chapter summarises some recent developments in understanding the pathogenesis of AD linking Aβ-induced oxidative stress, mitochondrial dysfunction, role of APE1 and phytochemicals toward AD therapeutics.

AB - Alzheimer’s disease (AD) is an important public health problem which affects millions of people worldwide. The major pathological hallmarks associated with AD are the accumulation of amyloid beta (Aβ) in senile plaques and neurofibrillary tangles (NFT) made up of hyperphosphorylated tau proteins. New findings suggest that oligomeric Aβ is a more toxic species than fibrillar Aβ relevant to AD pathology. Although the molecular mechanism(s) underlying the disease is not identified completely, various factors have been implicated in the development of AD. Accumulating evidences point towards the role of oxidative stress and mitochondrial dysfunction in the pathogenesis of AD and recognise them as an early event in AD development. Ageing is considered the greatest risk factor for AD and is linked to oxidative stress which causes accumulation of somatic mutations in mitochondrial DNA (mtDNA) over time and leads to genome instability and mitochondrial dysfunction. Recent studies on AD patients and transgenic mouse models suggest that amyloid precursor protein (APP) and Aβ localise to mitochondria, interact with mitochondrial proteins, disrupt electron transport chain (ETC), increases reactive oxygen species (ROS) level, impair axonal mitochondrial trafficking, thus leading to synaptic damage and cognitive decline associated with AD. It is not known whether accumulation of Aβ is the cause or outcome of declining mitochondrial function in AD. In order to counteract oxidative stress and maintain genome integrity, various DNA repair pathways exist, base excision repair (BER) pathway being the predominant pathway for repairing oxidised base lesions in neuronal cells. APE1 is the central enzyme of the BER pathway, having both repair and redox activities and shown to enhance neuronal survival after oxidative stress. Newer studies are revealing the role of APE1 in maintenance of mitochondrial genome repair and function. In this scenario, antioxidant-based therapy, which could reduce oxidative stress and modulate the activities of APE1, can serve as effective treatment providing neuroprotection in AD. This book chapter summarises some recent developments in understanding the pathogenesis of AD linking Aβ-induced oxidative stress, mitochondrial dysfunction, role of APE1 and phytochemicals toward AD therapeutics.

KW - Alzheimer’s disease

KW - Amyloid beta

KW - APE1/Ref-1

KW - Mitochondria

KW - Oxidative stress

KW - Phytochemicals

UR - http://www.scopus.com/inward/record.url?scp=84927570667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927570667&partnerID=8YFLogxK

U2 - 10.1007/978-81-322-2035-0_13

DO - 10.1007/978-81-322-2035-0_13

M3 - Chapter

AN - SCOPUS:84927570667

SN - 9788132220350

SN - 9788132220343

SP - 175

EP - 207

BT - Free Radicals in Human Health and Disease

PB - Springer India

ER -